IDA-FLAG chemo regimen effective for refractory AML and ALLInpharma Weekly -doi:10.2165/00128413-200615610-00026NoneSpringer International PublishingInpharma Weekly
FLAG方案与CAG方案治疗复发_难治性急性髓系白血病的疗效比较
School of Medical Imaging, Mudanjiang Medical University, Heilongjiang, Mudanjiang 157011, China [Abstract] Transcatheter arterial chemoembolization (TACE) is the most common regimen for the initial treatment of patients with unresectable liver cancer in China. Its limitation includes incomplete tumor ...